• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Sheba Medical Center & Salignostics to Develop Saliva Test for Early Oral Cancer Detection

by Fred Pennic 05/28/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Sheba Medical Center & Salignostics to Develop Saliva Test for Early Oral Cancer Detection

What You Should Know: 

– Jerusalem-based Salignostics, a company specializing in rapid tests using saliva samples, has joined forces with ARC Innovation, the innovation arm of Sheba Medical Center, in a groundbreaking initiative. 

– The strategic partnership is focused on developing a revolutionary test for early detection of oral cavity cancer through saliva analysis.

Early Detection: A Critical Need in Oral Cancer

Globally, over 400,000 individuals are diagnosed with oropharyngeal cancer annually. The stark reality is that the average five-year survival rate after diagnosis is a mere 50%. This grim statistic underscores the critical need for a more effective early detection tool. Current methods primarily rely on physical examination and tissue biopsies, often identifying the disease only after it has progressed.

A Pioneering Approach to Cancer Detection

Sheba Medical Center’s Oral and Maxillofacial Surgery Institute, led by Dr. Alex Dobrian, is spearheading the cooperation and research efforts. Other key figures involved include Dr. Eran Alon (Ear, Nose and Throat Department), Prof. Iris Barshak (Institute of Pathology), and Prof. Gidi Rechavi (Director, Sheba Cancer Research Center).

The saliva test being jointly developed by Salignostics and Sheba has the potential to be a game-changer. It could become one of the first in the world to enable early detection of oral cavity cancer using a simple saliva sample. This approach, if successful, could pave the way for similar tests for other cancer types.

Saliva: A Promising Avenue for Early Detection

The decision to focus on oral cavity cancer as the initial target stems from the direct contact saliva has with infected tissues. This contact increases the likelihood of detecting disease markers, potentially leading to the identification of a significant portion of tumors at an early stage. Following successful proof-of-concept, the team will explore developing solutions for other cancers, including head and neck cancers.

Leveraging Salignostics’ Proven Platform

The foundation of this collaboration lies in Salignostics’ innovative platform for saliva processing. This platform is the culmination of decades of research and has already yielded rapid tests for pregnancy, COVID-19, and more, available for home use.

 “The potential for early detection of head and neck cancer in general, and oral cavity cancer in particular, is tremendous and may have a very significant impact on the ability of these complex patients to recover. The connection between Sheba’s leading head and neck team and Salignostics’ versatile and groundbreaking technology can bring great diagnostic news,” said Dr. Alex Dobrian, director of the Oral and Maxillofacial Surgery Institute at Sheba Medical Center.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |